Density Labs YK11 The most powerful SARM available. As a myostatin inhibitor, YK-11 helps to reduce muscle myostatin protein effectively, leading the body to a dramatic increase in muscle
Density Labs YK-11 6mg capsules
  • Load image into Gallery viewer, Density Labs YK11 The most powerful SARM available. As a myostatin inhibitor, YK-11 helps to reduce muscle myostatin protein effectively, leading the body to a dramatic increase in muscle
  • Load image into Gallery viewer, Density Labs YK-11 6mg capsules

Density Labs YK-11 6mg capsules

Regular price
£44.99
Sale price
£44.99
Regular price
Sold out
Unit price
per 
Tax included. Shipping calculated at checkout.

YK11 MYOSTATIN INHIBITOR

6mg per Capsule  x 60 capsules

YK11 is a selective androgen receptor modulator (SARM), which activates AR (androgen receptor) without the N/C interaction. There have been studies that have shown the positive impact of YK11 on myostatin inhibitor. That means it helps to build muscle primarily. Another study suggests that it has the potential to stimulate bone-building proteins to help improve bone health. Even though these studies have confirmed the benefits of YK11 and no side effects, further research is needed. Hence, you can get YK11 in a supplement shop and athletes have said it really helped to increase mass.

How does it work?

YK11 sarm has a similar chemical structure to DHT (dihydrotestosteron – sex hormone) and this is shown by the way it binds to androgen receptors. The body produces DHT naturally for the purpose of promoting prostate health, hair growth, and appropriate puberty development.

YK11 sarm accelerates osteoblast cell proliferation similar to DHT. If you are interested in to more technical terminology, one study claims:

In conclusion, YK11 induces myogenic differentiation via AR-dependent induction of Fst expression. Although DHT did not increase Fst mRNA, both YK11 and DHT elevated the expression of MyHC protein and MRFs’ mRNA, implying that DHT enhances myogenic differentiation through an Fst-independent pathway. In addition to the Fst pathway, YK11 may share this Fst-independent pathway with DHT.

In this report, YK11 was shown to be an appropriate anabolic SARM. However, further investigation is required to elucidate the mechanisms of the differential activation of the Fst pathway by YK11 and DHT.

 

NB  THIS IS A RESEARCH CHEMICAL NOT FOR HUMAN CONSUMPTION